Research Article
One-Year Clinical Outcome of Inspiron Stent in All-Comers Population (Analysis from 790 Consecutive Patients)
Table 4
Comparison between Inspiron and other DES (1-year follow-up).
| ā | InspironTM current registry | PromusTM,12 | SynergyTM,13 | Resolute OnyxTM,11 | UltimasterTM,14 |
| Number of patients | 790 | 988 | 846 | 252 | 1660 | Diabetes | 43.9% | 35.2% | 31.1% | 46.2% | 29% | Non-STEMI | 34.3% | 7.3% | 25.9% | 24.4% | 12.5% | STEMI | 40.4% | 5.8% | 0 | 8.8% | 10.5% | Stent thrombosis | 0.2% | 0.5% | 0.4% | 0.7% | 0.9% | Target lesion revascularization | 2.1 % | 1.9% | 2.0% | 4.4% | 3.2% |
|
|